Myth: Any website with Canada in the name is a safe, regulated pharmacy
Intended for qualified research use only
We will tell you that during the consultation if it applies to your situation
While these medications cannot be denied for their weight loss success, they do have some serious concerns
The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
Depending on the GC selected, and the dosage administered, GC can remain in the body at levels high enough to result in an Adverse Analytical Finding (AAF) for days to weeks after administration
